These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33843997)
1. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic. Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997 [TBL] [Abstract][Full Text] [Related]
2. The impact of cumulative colorectal cancer screening delays: A simulation study. Rutter CM; Inadomi JM; Maerzluft CE J Med Screen; 2022 Jun; 29(2):92-98. PubMed ID: 34894841 [TBL] [Abstract][Full Text] [Related]
3. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women. Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025 [TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I; Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185 [TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer screening with fecal immunochemical testing: a community-based, cross-sectional study in average-risk individuals in Nigeria. Alatise OI; Dare AJ; Akinyemi PA; Abdulkareem FB; Olatoke SA; Knapp GC; Kingham TP; Lancet Glob Health; 2022 Jul; 10(7):e1012-e1022. PubMed ID: 35714629 [TBL] [Abstract][Full Text] [Related]
6. Delivery of Cervical and Colorectal Cancer Screenings During the Pandemic in Community Health Centers: Practice Changes and Recovery Strategies. Huguet N; Danna M; Baron A; Hall J; Hodes T; O'Malley J; Holderness H; Marino M; DeVoe JE; Cohen DJ Med Care; 2023 Aug; 61(8):554-561. PubMed ID: 37310241 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand. Phisalprapa P; Supakankunti S; Chaiyakunapruk N J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247 [No Abstract] [Full Text] [Related]
8. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy. Cheng SY; Chen CF; He HC; Chang LC; Hsu WF; Wu MS; Chiu HM J Gastroenterol Hepatol; 2021 Jun; 36(6):1614-1619. PubMed ID: 33217055 [TBL] [Abstract][Full Text] [Related]
9. [Participation indicators of colorectal screenings in Hungary between 2008-2021]. Kívés Z; Bódis J; Hunyady B; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Vajda R; Boncz I Magy Onkol; 2022 Oct; 66(3):209-217. PubMed ID: 36200501 [TBL] [Abstract][Full Text] [Related]
10. Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity. Alba C; Zheng Z; Wadhera RK JAMA Health Forum; 2024 Feb; 5(2):e235058. PubMed ID: 38306093 [TBL] [Abstract][Full Text] [Related]
11. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults. Sharma T Public Health; 2020 May; 182():70-76. PubMed ID: 32179290 [TBL] [Abstract][Full Text] [Related]
12. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. Chen RC; Haynes K; Du S; Barron J; Katz AJ JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015 [TBL] [Abstract][Full Text] [Related]
13. A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study. Ishibashi F; Shida D; Suzuki S; Nagai M; Mochida K; Morishita T Int J Colorectal Dis; 2022 Dec; 37(12):2543-2546. PubMed ID: 36383225 [TBL] [Abstract][Full Text] [Related]
14. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates]. Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828 [TBL] [Abstract][Full Text] [Related]
15. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial. Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161 [TBL] [Abstract][Full Text] [Related]
16. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study. Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M Elife; 2023 Jan; 12():. PubMed ID: 36695411 [TBL] [Abstract][Full Text] [Related]
17. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study. Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931 [TBL] [Abstract][Full Text] [Related]
18. Postoperative Outcomes of Screen-Detected vs Non-Screen-Detected Colorectal Cancer in the Netherlands. de Neree Tot Babberich MPM; Vermeer NCA; Wouters MWJM; van Grevenstein WMU; Peeters KCMJ; Dekker E; Tanis PJ; JAMA Surg; 2018 Dec; 153(12):e183567. PubMed ID: 30285063 [TBL] [Abstract][Full Text] [Related]
19. Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms: A Randomized Clinical Trial. Brenner H; Calderazzo S; Seufferlein T; Ludwig L; Dikopoulos N; Mangold J; Böck W; Stolz T; Eisenbach T; Block T; Kopp-Schneider A; Czock D; Tikk K JAMA; 2019 May; 321(17):1686-1692. PubMed ID: 31063574 [TBL] [Abstract][Full Text] [Related]
20. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data. Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]